NCT06471582

Brief Summary

The primary aim of this clinical trial is to evaluate how fasted prolonged exercise may influence circulating reproductive hormones (i.e., estradiol, progesterone, luteinizing hormone) and menstrual cycle length when energy availability is maintained at or above 30 kcal/kg lean body mass/ day among women who regularly do running or cycling exercise. A secondary aim is to determine the effects of fasted prolonged exercise on serum leptin and cortisol. Participants will be asked to do the following over a \~3 month enrollment period:

  • attend a laboratory visit at the beginning of the study to have their resting metabolic rate, aerobic fitness, and body composition tested
  • monitor their menstrual cycle length, urine hormones, perceived stress levels, and diet for \~3 months
  • complete 3, 90-minute exercise sessions on a stationary bike or treadmill either fed (consuming a carbohydrate meal 1 h prior and 0.7 g carbohydrate/ kg body mass/ h during exercise) or fasted (consuming no meal prior and no carbohydrates during exercise) during month \~3
  • saliva samples will be taken prior to and after 90-minute exercise sessions for quantification of leptin and cortisol

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Aug 2024Aug 2027

First Submitted

Initial submission to the registry

June 17, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

June 17, 2024

Last Update Submit

April 27, 2026

Conditions

Keywords

functional hypothalamic amenorrheamenstrual cyclefemale athlete

Outcome Measures

Primary Outcomes (4)

  • Urinary estrone-3-glucuronide (E3G)

    ng/mL

    3 months

  • Urinary pregnanediol glucuronide (PdG)

    ug/mL

    3 months

  • Urinary luteinizing hormone (LH)

    MIU/mL

    3 months

  • Menstrual cycle length

    days

    3 months

Secondary Outcomes (2)

  • Salivary cortisol

    3 days

  • Salivary leptin

    3 days

Study Arms (2)

Fed with Carbohydrates

EXPERIMENTAL

Participants will complete 3, 90-minute stationary cycle or treadmill exercise sessions 1 h after consuming a meal containing 1 g carbohydrate/ kg body weight. During exercise, they will consume an artificially sweetened beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose.

Dietary Supplement: Artificially Sweetened Carbohydrate Beverage

Fasted without Carbohydrates

PLACEBO COMPARATOR

Participants will complete 3, 90-minute stationary cycle or treadmill exercise sessions following an overnight fast. During exercise, they will consume an artificially sweetened beverage containing no carbohydrates.

Dietary Supplement: Artificially Sweetened Beverage

Interventions

Beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose and artificial sweetener

Fed with Carbohydrates

Beverage containing no carbohydrates or kilocalories and an artificial sweetener

Fasted without Carbohydrates

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • participates in structured running or cycling exercise for at least 30 minutes on 3 or more days per week
  • accustomed to exercising for 90 minutes or more
  • has regular periods every 21-35 days
  • have not taken hormonal contraceptives for at least the past 6 months
  • is not currently or trying to become pregnant or breastfeeding, and has not been pregnant or breastfeeding in the past 12 months
  • does not currently have a diagnosis of a major menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, ovarian cancer, ovarian insufficiency, uterine or endometrial cancer)
  • does not currently have a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes, congenital adrenal hyperplasia)
  • does not currently have a major cardiovascular or respiratory disease

You may not qualify if:

  • miss more than 7 consecutive days of aerobic activity (i.e., running, cycling, cross training)
  • demonstrate clinical low energy availability as defined as energy availability \<30 kcal/kg fat free mass
  • report menstrual cycle lengths \<21 or \>35 days in the first 2 months of at-home monitoring
  • do not demonstrate an anticipated rise in luteinizing hormone and progesterone in the first 2 months of at-home monitoring
  • begin taking a hormonal contraceptive
  • become pregnant
  • are diagnosed with a menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, ovarian cancer, ovarian insufficiency, uterine, or endometrial cancer)
  • are diagnosed with a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes)
  • are diagnosed with a major cardiovascular or respiratory disease
  • are unable to follow instructions for any of the procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

William J. Hybl Sports Medicine and Performance Center

Colorado Springs, Colorado, 80918, United States

RECRUITING

MeSH Terms

Conditions

Menstruation Disturbances

Interventions

Artificially Sweetened Beverages

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Central Study Contacts

Marissa Baranauskas, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 17, 2024

First Posted

June 24, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations